Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Non-Current Assets (2016 - 2026)

Anika Therapeutics has reported Other Non-Current Assets over the past 17 years, most recently at $4.3 million for Q1 2026.

  • Quarterly Other Non-Current Assets changed N/A to $4.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Mar 2026, changed N/A year-over-year, with the annual reading at $4.0 million for FY2025, 28.68% down from the prior year.
  • Other Non-Current Assets was $4.3 million for Q1 2026 at Anika Therapeutics, up from $4.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $36.3 million in Q4 2023 and troughed at $4.0 million in Q4 2025.
  • The 5-year median for Other Non-Current Assets is $18.1 million (2023), against an average of $15.8 million.
  • Year-over-year, Other Non-Current Assets surged 110.84% in 2023 and then tumbled 84.42% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $17.2 million in 2022, then skyrocketed by 110.84% to $36.3 million in 2023, then tumbled by 84.42% to $5.7 million in 2024, then dropped by 28.68% to $4.0 million in 2025, then increased by 6.67% to $4.3 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Other Non-Current Assets are $4.3 million (Q1 2026), $4.0 million (Q4 2025), and $5.5 million (Q3 2025).